, October 2017 — Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models. European Radiology vol. 27, n° 10, dir. {Springer Verlag} p. 4435-4444
, February 2017 — Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors. Clinical Cancer Research vol. 23, n° 4, dir. {American Association for Cancer Research} p. 1001-1011